Matt Hernandez, MD, PhD, Clinical Microbiology Fellow will join Stanford Faculty, July 20245/16/2024 We are delighted to announce that Matt Hernandez will become Assistant Director of Clinical Microbiology in the Department of Pathology Stanford University Medical Center, Palo Alto CA. He is getting ready to pack up his bags and head West with Aeromonas hydrophila in tow (in the proper DOT-approved shipping container of course). Congratulations Matt!
0 Comments
https://asm.org/press-releases/2024/february/65-fellows-elected-into-american-academy-of-microb along with collaborator, Ashlee Earl, Head of the Bacterial Genomics Group, at the Broad Institute, and Brennan-Krohn and Kirby lab collaborator,
TECAN D300, TECAN M1000 Pro, TECAN Magic Prep, Illumina MiSeq, Qiagen CLC Genomics Workbench, and Matt got a workout! I loved his pulling out NGS reads from rectal swab sample demonstrating bowel colonization with (presumptively) same organism! BAARN 2023 - Boston Area Antimicrobial Resistance Network Meeting.  Just out - CPEP Faculty Member, Alex McAdam, President-Elect, American Society of Microbiology12/14/2023 Congratulations, Alex!!!!
As if he weren't busy enough as Editor-in-Chief of the Journal of Clinical Microbiology, Alex is on the ballot for President-Elect of ASM. Best wishes, Alex!
More information can be found at the following links:
https://www.bidmc.org/about-bidmc/collaboration https://www.dana-farber.org/about/partners-affiliates/dana-farber-beth-israel-deaconess-cancer-collaboration https://www.bostonglobe.com/2023/10/16/opinion/cancer-dana-farber-beth-israel-mass-general-brigham/ Learning to Count the Hard Way: Measuring Diversity in the Microbiome and Beyond
presented by: Ramy Arnaout, MD, DPhil Dr. Arnaout is the Associate Director of the Clinical Microbiology Laboratories at Beth Israel Deaconess Medical Center and Associate Professor of Pathology at Harvard Medical School and President of the ASM Northeast Branch. His research lies at the intersection of computation, immunology, and infectious disease and brings mathematical and physics-based approaches to bear on several problems, including deciphering large-scale antibody and T-cell receptor immunomes. Today’s talk is about a key tool in the toolkit: measuring diversity in complex systems. Learning to do so led the laboratory on an enlightening (and humbling) journey from immunomes to information theory to microbiomes and beyond. Staking out new territory on the ribosome for antibiotic development presented by: James E. Kirby, MD, D(ABMM) Dr. Kirby is an NIH-funded Principal Investigator in the Experimental Pathology Division of Beth Israel Deaconess Medical Center, Boston, MA, Director of the Clinical Microbiology Laboratory at BIDMC; Program Director of the Medical Microbiology Fellowships at BIDMC; and Professor of Pathology at Harvard Medical School, Boston, MA. He was past president of the Northeast Branch-ASM from 2009-2012. Dr. Kirby will talk about his collaborative efforts to develop antibiotics targeting gram-negative ESKAPE pathogens. He will discuss the emerging threat from such pathogens; the difficulty in developing new drugs to treat them; and the activity; action; and goals and strategies for development of rediscovered natural products. Registration |
RSS Feed